| Date | Title | Description | Source |
| 09.04.2024 | Nicox : Assemblée Générale Ordinaire et Extraordinaire 2024... | Communiqué de presse
Nicox : Assemblée Générale Ordinaire et Extraordinaire 2024
9 avril 2024 – diff... | einpresswi... |
| 09.04.2024 | Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting | Press Release
Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting
April 9, 2024 – release at ... | einpresswi... |
| 13.03.2024 | Nicox Updates on Corporate, Pipeline and Financing Perspecti... | - | globenewsw... |
| 05.03.2024 | Nicox Announces Presentation of Data on NCX 470 at the 2024 ... | - | globenewsw... |
| 06.02.2024 | Nicox : Présentations au prochain Congrès Annuel 2024 de l’A... | Communiqué de presse
Nicox : Présentations au prochain Congrès Annuel 2024 de l’Association for Rese... | einpresswi... |
| 06.02.2024 | Nicox announces presentations at the upcoming Association fo... | Press Release
Nicox announces presentations at the upcoming Association for Research in Vision and O... | einpresswi... |
| 21.09.2023 | Revolutionising Ophthalmology: Are Nitric Oxide Donating Dru... | “`html
Key Takeaways:
NicOx is a biopharmaceutical company based in Valbonne, France, specialising ... | eustartup.... |
| 19.07.2023 | Nicox Provides Second Quarter 2023 Financial and Business Hi... | Press Release
Nicox Provides Second Quarter 2023 Financial and Business Highlights
Net revenue1 of €... | einpresswi... |
| 19.07.2023 | Nicox : Résumé financier et point d’activité du deuxième tri... | Communiqué de presse
Nicox : Résumé financier et point d’activité du deuxième trimestre 2023
Chiffre... | einpresswi... |
| 03.07.2023 | Nicox : Présentation au Congrès Mondial du Glaucome de donné... | Communiqué de presse
Nicox : Présentation au Congrès Mondial du Glaucome de données sur le NCX 470 p... | einpresswi... |
| 03.07.2023 | Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design D... | Press Release
Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data and Additional Subset ... | einpresswi... |
| 21.03.2023 | Nicox Announces Presentations of Additional NCX 470 Data at ... | Press Release
Nicox Announces Presentations of Additional NCX 470 Data at the Upcoming World Glaucom... | einpresswi... |
| 21.03.2023 | Nicox : Présentations de données supplémentaires sur le NCX ... | Communiqué de presse
Nicox : Présentations de données supplémentaires sur le NCX 470 au prochain Con... | einpresswi... |
| 24.01.2023 | Nicox to Participate in Financial, Pharmaceutical Industry a... | Press Release
Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1... | einpresswi... |
| 22.11.2022 | Nicox Raises €10 Million in Private Placement | - | globenewsw... |
| 22.11.2022 | Nicox Raises €10 Million in Private Placemen | - | globenewsw... |
| 31.10.2022 | Nicox Reports Achieving Primary Objective in Mont Blanc, the... | Press Release
Nicox Reports Achieving Primary Objective in Mont Blanc, the First Phase 3 Glaucoma Tr... | globenewsw... |
| 19.10.2022 | Nicox Provides Third Quarter 2022 Financial and Business Hig... | Press Release
Nicox Provides Third Quarter 2022 Financial and Business Highlights
Topline results of... | globenewsw... |
| 30.09.2022 | Nicox confirme son éligibilité au PEA-PME | Communiqué de presse
Nicox confirme son éligibilité au PEA-PME
30 septembre 2022
Sophia Antipolis, F... | globenewsw... |
| 19.09.2022 | Nicox Announces Last Patients Complete Final Visit in NCX 47... | Press Release
Nicox Announces Last Patients Complete Final Visit in NCX 470 Phase 3 Mont Blanc Glauc... | globenewsw... |
| 16.09.2022 | Nicox Provides First Half 2022 Business Update and Financial... | Press Release
Nicox Provides First Half 2022 Business Update and Financial Results
Topline results f... | einpresswi... |
| 16.09.2022 | Nicox Provides First Half 2022 Business Update and Financial... | Press Release
Nicox Provides First Half 2022 Business Update and Financial Results
Topline results f... | globenewsw... |
| 15.09.2022 | Nicox : Rapport semestriel 2022 | Communiqué de presse
Nicox : Rapport semestriel 2022
15 septembre 2022
Sophia Antipolis, France
Le r... | globenewsw... |
| 03.08.2022 | Nicox to Participate in Financial and Scientific Events in Q... | Press Release
Nicox to Participate in Financial and Scientific Events in Q3 2022
August 3, 2022 – re... | globenewsw... |
| 20.07.2022 | Nicox Provides Second Quarter 2022 Financial and Business Hi... | Press Release
Nicox Provides Second Quarter 2022 Financial and Business Highlights
Enrollment comple... | globenewsw... |
| 08.07.2022 | Nicox: 2022 Extraordinary Shareholder Meeting | Press Release
Nicox: 2022 Extraordinary Shareholder Meeting
July 8, 2022 – release at 7:30 am CET
So... | globenewsw... |
| 07.07.2022 | Nicox Announces Publication of NCX 470 Results Demonstrating... | Press Release
Nicox Announces Publication of NCX 470 Results Demonstrating Improvements to Ocular He... | globenewsw... |
| 05.07.2022 | Nicox: Half-year liquidity contract statement for NICOX | Press Release
Nicox: Half-year liquidity contract statement for NICOX
July 5, 2022 – release at 7:30... | globenewsw... |
| 20.06.2022 | Börje Haraldsson appointed CEO of Oncorena AB | Börje Haraldsson appointed CEO of Oncorena AB
Mon, Jun 20, 2022 08:30 CET Report this content
LUND, ... | news.cisio... |
| 14.06.2022 | Nicox: 2022 Ordinary Shareholder Meeting | Press Release
Nicox: 2022 Ordinary Shareholder Meeting
June 14, 2022 – release at 7:30 am CET
Sophia... | globenewsw... |
| 03.06.2022 | Nicox: 2022 Extraordinary Shareholder Meeting | Press Release
Nicox: 2022 Extraordinary Shareholder Meeting
June 3, 2022 - release at 8:30 am CET
So... | globenewsw... |
| 03.06.2022 | Nicox Accelerates Topline Results from NCX 470 Mont Blanc Ph... | Press Release
Nicox Accelerates Topline Results from NCX 470 Mont Blanc Phase 3 Glaucoma Trial to No... | globenewsw... |
| 19.05.2022 | Nicox : Mise à disposition d'un amendement au Document d’enr... | Communiqué de presse
Nicox : Mise à disposition d'un amendement au Document d’enregistrement univers... | globenewsw... |
| 16.05.2022 | Nicox Announces a New Governance Structure | Press Release
Nicox Announces a New Governance Structure
New governance structure with a separation ... | globenewsw... |
| 04.05.2022 | Nicox: 2022 Ordinary Shareholder Meeting | Press Release
Nicox: 2022 Ordinary Shareholder Meeting
May 4, 2022 – release at 7:30 am CET
Sophia A... | globenewsw... |
| 02.05.2022 | Nicox at ARVO 2022: Presentation of clinical Phase 2 results... | Press Release
Nicox at ARVO 2022: Presentation of clinical Phase 2 results on NCX 4251 and new non-c... | globenewsw... |
| 28.04.2022 | Nicox Reports 2021 Financial Results and First Quarter 2022 ... | Press Release
Nicox Reports 2021 Financial Results and First Quarter 2022 Financial Highlights and P... | globenewsw... |
| 11.04.2022 | Nicox’s NCX 470 Dolomites Phase 2 Results Published in Journ... | Press Release
Nicox’s NCX 470 Dolomites Phase 2 Results Published in Journal of Glaucoma
April 11, 2... | globenewsw... |
| 02.03.2022 | Nicox’s Partner Fera Pharmaceuticals Obtains Orphan Drug Des... | Press Release
Nicox’s Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA... | globenewsw... |
| 01.03.2022 | Nicox’s Partner Ocumension Obtains Positive Phase 3 Clinical... | Press Release
Nicox’s Partner Ocumension Obtains Positive Phase 3 Clinical Trial Results for ZERVIAT... | globenewsw... |
| 23.02.2022 | Nicox Announces VYZULTA Now Commercialized in 7 Territories ... | Press Release
Nicox Announces VYZULTA Now Commercialized in 7 Territories and Approved in Further 9 ... | globenewsw... |
| 21.02.2022 | Nicox Granted New Patent for NCX 470 in China, Extending Cov... | Press Release
Nicox Granted New Patent for NCX 470 in China, Extending Coverage to 2039
February 21,... | globenewsw... |
| 08.02.2022 | Nicox’s Positive FDA Meeting Shows Clear Path for NCX 4251 i... | Press Release
Nicox’s Positive FDA Meeting Shows Clear Path for NCX 4251 in Dry Eye
Statistically si... | globenewsw... |
| 21.01.2022 | Nicox Provides Fourth Quarter 2021 Business and Financial Hi... | Press Release
Nicox Provides Fourth Quarter 2021 Business and Financial Highlights
Mont Blanc Phase ... | globenewsw... |
| 06.01.2022 | Nicox: Half-year liquidity contract statement for NICOX | Press Release
Nicox: Half-year liquidity contract statement for NICOX
January 6, 2022 – release at 7... | globenewsw... |
| 05.01.2022 | Nicox European Patent Seals ZERVIATE Major Market Coverage t... | Press Release
Nicox European Patent Seals ZERVIATE Major Market Coverage to 2030
Patent coverage for... | globenewsw... |
| 16.12.2021 | Nicox Announces First Patient in China screened in the ongoi... | Press Release
Nicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 ... | globenewsw... |
| 13.12.2021 | Nicox Appoints Doug Hubatsch as new Chief Scientific Officer... | Press Release
Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-... | globenewsw... |
| 10.12.2021 | Nicox : Mise à disposition d'un prospectus d’admission d'act... | Communiqué de presse Nicox : Mise à disposition d'un prospectus d’admission d'actions nouvelles 10 d... | globenewsw... |
| 09.12.2021 | Nicox : Mise à disposition d'un amendement au Document d’enr... | Communiqué de presse Nicox : Mise à disposition d'un amendement au Document d’enregistrement univers... | globenewsw... |
| 09.12.2021 | Nicox Restructures Kreos Capital Bond Financing Agreement an... | Press Release
Nicox Restructures Kreos Capital Bond Financing Agreement and Raises €15 Million in Pr... | globenewsw... |
| 30.11.2021 | Nicox’s Positive Post Hoc Results from NCX 4251 Phase 2b Mis... | Press Release
Nicox’s Positive Post Hoc Results from NCX 4251 Phase 2b Mississippi Trial Suggest Pat... | globenewsw... |
| 17.11.2021 | Nicox is Granted Patent for Blepharitis Product Candidate NC... | Press Release
Nicox is Granted Patent for Blepharitis Product Candidate NCX 4251 in Europe
Newly gra... | globenewsw... |
| 10.11.2021 | Nicox’s NCX 470 Dolomites Phase 2 Results in Glaucoma Patien... | Press Release
Nicox’s NCX 470 Dolomites Phase 2 Results in Glaucoma Patients to be Presented at the ... | globenewsw... |
| 19.10.2021 | Nicox Provides Third Quarter 2021 Business and Financial Hig... | Press Release
Nicox Provides Third Quarter 2021 Business and Financial Highlights
VYZULTA® and ZERVI... | globenewsw... |
| 13.10.2021 | Nicox to present at the OIS Glaucoma Virtual Innovation Show... | FOR INFORMATION
Nicox to present at the OIS Glaucoma Virtual Innovation Showcase
October 13, 2021
So... | globenewsw... |
| 27.09.2021 | Nicox : First Half 2021 Financial Results and Business Updat... | Press Release
Nicox First Half 2021 Financial Results and Business Update
H1 2021 net revenue1 of €1... | marketscre... |
| 02.07.2021 | Nicox : Announces Last Patient Completed NCX 4251 Mississipp... | Press Release
Nicox Announces Last Patient Completed NCX 4251 Mississippi Phase 2b Blepharitis Trial... | marketscre... |
| 04.05.2021 | NICOX SA.
Nicox : Licensee Bausch + Lomb Launches VYZULTA® ... | Press Release
Nicox's Licensee Bausch + Lomb Launches VYZULTA® (latanoprostene bunod ophthalmic solu... | marketscre... |
| 04.05.2021 | NICOX SA.
Nicox : Licensee Bausch + Lomb Launches VYZULTA® ... | Press Release
Nicox’s Licensee Bausch + Lomb Launches VYZULTA® (latanoprostene bunod ophthalmic solu... | marketscre... |
| 22.04.2021 | NICOX SA.
U.S. Patents for Nicox's Latanoprostene Bunod, Co... | Press Release
U.S. Patents for Nicox’s Latanoprostene Bunod, Commercialized as VYZULTA®, Eligible fo... | marketscre... |
| 05.03.2021 | Nicox: 2021 Extraordinary and Ordinary Shareholder Meetings | Press Release
Nicox: 2021 Extraordinary and Ordinary Shareholder Meetings
March 5, 2021
Sophia Antip... | globenewsw... |
| 02.03.2021 | Nicox Provides Video Update on Latest Developments | FOR INFORMATION
Nicox Provides Video Update on Latest Developments
March 2, 2021 – release at 7:30 a... | globenewsw... |
| 02.03.2021 | Nicox fait un point sur les récentes actualités de la Sociét... | POUR INFORMATION
Nicox fait un point sur les récentes actualités de la Société dans une vidéo
2 mars... | globenewsw... |
| 01.03.2021 | Nicox Announces 2020 Financial Results and 2021 Key Mileston... | Press Release
Nicox Announces 2020 Financial Results and 2021 Key Milestones
Net revenue1 of €12.9 m... | globenewsw... |
| 01.03.2021 | Nicox : Résultats financiers 2020 et étapes clé pour 2021 | Communiqué de presse
Nicox : Résultats financiers 2020 et étapes clé pour 2021
Le chiffre d’affaire ... | globenewsw... |
| 15.02.2021 | Nicox’s U.S. Licensee Eyevance Expands U.S. Promotion of ZER... | Press Release
Nicox’s U.S. Licensee Eyevance Expands U.S. Promotion of ZERVIATE® In Agreement with H... | globenewsw... |
| 09.02.2021 | Bausch Health Announces VYZULTA® (latanoprostene bunod ophth... | | prnewswire... |
| 20.10.2020 | NICOX S.A.
Nicox S A : Announces Third Quarter 2020 Busines... | Press Release
Nicox Announces Third Quarter 2020 Business Update and Financial Highlights
Selection ... | marketscre... |
| 20.10.2020 | NICOX S.A.
Nicox S A : Announces Third Quarter 2020 Busines... | Press Release
Nicox Announces Third Quarter 2020 Business Update and Financial Highlights
Selection ... | marketscre... |
| 20.10.2020 | NICOX S.A.
Nicox Announces Third Quarter 2020 Business Upda... | Press Release
Nicox Announces Third Quarter 2020 Business Update and Financial Highlights
Selection ... | marketscre... |
| 10.07.2020 | NICOX S.A.
Nicox Partner Ocumension Completes Successful Ho... | Press Release
Nicox Partner Ocumension Completes Successful Hong Kong IPO at an approximately US$1,0... | marketscre... |
